Clinical Trial of High Dose CoQ10 in ALS.
Phase of Trial: Phase II
Latest Information Update: 16 Mar 2011
At a glance
- Drugs Ubidecarenone (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Therapeutic Use
- Acronyms QALS
- 16 Jun 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 16 May 2006 New trial record.